BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 20814256)

  • 21. Advances in behavioral genetics: mouse models of autism.
    Moy SS; Nadler JJ
    Mol Psychiatry; 2008 Jan; 13(1):4-26. PubMed ID: 17848915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome.
    Hampson DR; Adusei DC; Pacey LK
    Biochem Pharmacol; 2011 May; 81(9):1078-86. PubMed ID: 21333634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.
    Berry-Kravis E
    Pediatr Neurol; 2014 Apr; 50(4):297-302. PubMed ID: 24518745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy.
    Millan MJ
    Neuropharmacology; 2013 May; 68():2-82. PubMed ID: 23246909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which neurodevelopmental disorders get researched and why?
    Bishop DV
    PLoS One; 2010 Nov; 5(11):e15112. PubMed ID: 21152085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragile X: a family of disorders.
    Chonchaiya W; Schneider A; Hagerman RJ
    Adv Pediatr; 2009; 56():165-86. PubMed ID: 19968948
    [No Abstract]   [Full Text] [Related]  

  • 27. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.
    Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational animal models of autism and neurodevelopmental disorders.
    Crawley JN
    Dialogues Clin Neurosci; 2012 Sep; 14(3):293-305. PubMed ID: 23226954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders.
    Gantois I; Popic J; Khoutorsky A; Sonenberg N
    Annu Rev Med; 2019 Jan; 70():167-181. PubMed ID: 30365357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic influences in autism.
    Smalley SL
    Psychiatr Clin North Am; 1991 Mar; 14(1):125-39. PubMed ID: 2047327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New innovations: therapeutic opportunities for intellectual disabilities.
    Picker JD; Walsh CA
    Ann Neurol; 2013 Sep; 74(3):382-90. PubMed ID: 24038210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetics of autism.
    Muhle R; Trentacoste SV; Rapin I
    Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rett syndrome: prevalence among Chinese and a comparison of MECP2 mutations of classic Rett syndrome with other neurodevelopmental disorders.
    Wong VC; Li SY
    J Child Neurol; 2007 Dec; 22(12):1397-400. PubMed ID: 18174559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetics and animal models in autistic disorder.
    Andres C
    Brain Res Bull; 2002 Jan; 57(1):109-19. PubMed ID: 11827743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathways to drug development for autism spectrum disorders.
    Hampson DR; Gholizadeh S; Pacey LK
    Clin Pharmacol Ther; 2012 Feb; 91(2):189-200. PubMed ID: 22205199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autism: in search of susceptibility genes.
    Lamb JA; Parr JR; Bailey AJ; Monaco AP
    Neuromolecular Med; 2002; 2(1):11-28. PubMed ID: 12230302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered Purinergic Signaling in Neurodevelopmental Disorders: Focus on P2 Receptors.
    Boccazzi M; Raffaele S; Zanettin T; Abbracchio MP; Fumagalli M
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood developmental disorders: an academic and clinical convergence point for psychiatry, neurology, psychology and pediatrics.
    Reiss AL
    J Child Psychol Psychiatry; 2009 Jan; 50(1-2):87-98. PubMed ID: 19220592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bibliography. Current world literature. Developmental disorders.
    Curr Opin Neurol; 2003 Apr; 16(2):221-30. PubMed ID: 12751467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.